{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T14:09:42Z","timestamp":1790690982251,"version":"4.1.0"},"reference-count":50,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T00:00:00Z","timestamp":1790640000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/doi.org\/10.1080\/policies-text-data-mining"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Review of Anti-infective Therapy"],"DOI":"10.1080\/14787210.2026.2740110","type":"journal-article","created":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T01:19:42Z","timestamp":1790385582000},"page":"1-8","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":0,"title":["Is fluoroquinolone use controversial?"],"prefix":"10.1080","author":[{"given":"Joseph M.","family":"Blondeau","sequence":"first","affiliation":[{"name":"Royal University Hospital and Saskatchewan Health Authority","place":["Saskatoon, Canada"]},{"name":"University of Saskatchewan","place":["Saskatoon, Canada"]},{"name":"University of Saskatchewan","place":["Saskatoon, Canada"]},{"name":"University of Saskatchewan","place":["Saskatoon, Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glenn S.","family":"Tillotson","sequence":"additional","affiliation":[{"name":"GST Micro LLC","place":["North, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2026,9,29]]},"reference":[{"key":"e_1_3_5_3_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciad196"},{"key":"e_1_3_5_4_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-025-11566-2"},{"key":"e_1_3_5_5_1","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2026.1833650"},{"key":"e_1_3_5_6_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa241"},{"key":"e_1_3_5_7_1","unstructured":"World Health Organization. WHO consolidated guidelines on tuberculosis: module 4: treatment and care. 2026 Jul 30. Available from: https:\/\/www.who.int\/publications\/i\/item\/9789240107243"},{"key":"e_1_3_5_8_1","doi-asserted-by":"publisher","DOI":"10.3389\/frabi.2026.1632790"},{"key":"e_1_3_5_9_1","unstructured":"World Health Organization. Global tuberculosis report 2025 - TB incidence. 2026 Sep 17. Available from: https:\/\/www.who.int\/teams\/global-programme-on-tuberculosis-and-lung-health\/tb-reports\/global-tuberculosis-report-2025\/tb-disease-burden\/1-1-tb-incidence"},{"key":"e_1_3_5_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jctube.2016.12.001"},{"key":"e_1_3_5_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2010.11.008"},{"key":"e_1_3_5_12_1","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens14060525"},{"key":"e_1_3_5_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(89)90048-X"},{"key":"e_1_3_5_14_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciw118"},{"key":"e_1_3_5_15_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/39.4.441"},{"key":"e_1_3_5_16_1","doi-asserted-by":"publisher","DOI":"10.4212\/cjhp.v68i4.1472"},{"key":"e_1_3_5_17_1","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics12081241"},{"key":"e_1_3_5_18_1","doi-asserted-by":"publisher","DOI":"10.3390\/ph17111537"},{"key":"e_1_3_5_19_1","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.160938"},{"key":"e_1_3_5_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2023.06.011"},{"issue":"9","key":"e_1_3_5_21_1","first-page":"651","article-title":"Update on the adverse effects of antimicrobial therapies in community practice","volume":"66","author":"Mohsen S","year":"2020","unstructured":"Mohsen S, Dickinson JA, Somayaji R. Update on the adverse effects of antimicrobial therapies in community practice. Can Fam Physician. 2020;66(9):651\u2013659.","journal-title":"Can Fam Physician"},{"key":"e_1_3_5_22_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkaf473"},{"key":"e_1_3_5_23_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.24892"},{"key":"e_1_3_5_24_1","doi-asserted-by":"publisher","DOI":"10.1002\/jcph.715"},{"key":"e_1_3_5_25_1","doi-asserted-by":"publisher","DOI":"10.5770\/cgj.28.835"},{"key":"e_1_3_5_26_1","unstructured":"Government of Canada. Summary safety review - fluoroquinolones - assessing the potential risk of persistent and disabling side effects. 2026 Apr 23. Available from: https:\/\/www.canada.ca\/en\/health-canada\/services\/drugs-health-products\/medeffect-canada\/safety-reviews\/summary-safety-review-fluoroquinolones-assessing-potential-risk-persistent-disabling-effects.html"},{"key":"e_1_3_5_27_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40264-023-01286-4"},{"key":"e_1_3_5_28_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkae440"},{"key":"e_1_3_5_29_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.36662"},{"issue":"12","key":"e_1_3_5_30_1","doi-asserted-by":"crossref","first-page":"ofab538","DOI":"10.1093\/ofid\/ofab538","article-title":"Ambulatory fluoroquinolone use in the United States, 2015\u20132019","volume":"8","author":"Umarje SP","year":"2021","unstructured":"Umarje SP, Alexander CG, Cohen AJ. Ambulatory fluoroquinolone use in the United States, 2015\u20132019. Open Forum Infect Dis. 2021;8(12):ofab538.","journal-title":"Open Forum Infect Dis"},{"key":"e_1_3_5_31_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciae403"},{"key":"e_1_3_5_32_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaf460"},{"issue":"3","key":"e_1_3_5_33_1","first-page":"i36","article-title":"Clinical practice guideline by Infectious Diseases Society of America (IDSA): 2025 guideline on management and treatment of complicated urinary tract infections: patient perspectives","volume":"82","author":"Trautner BW","year":"2025","unstructured":"Trautner BW, Cort\u00e9s-Penfield NW, Gupta K, et al. Clinical practice guideline by Infectious Diseases Society of America (IDSA): 2025 guideline on management and treatment of complicated urinary tract infections: patient perspectives. Clin Infect Dis. 2025;82(Supplement_3):i36\u2013i67.","journal-title":"Clin Infect Dis"},{"key":"e_1_3_5_34_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaf461"},{"key":"e_1_3_5_35_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaf462"},{"issue":"3","key":"e_1_3_5_36_1","first-page":"i36","article-title":"Clinical practice guideline by Infectious Diseases Society of America (IDSA): 2025 guideline on management and treatment of complicated urinary tract infections: selection of antibiotic therapy for complicated UTI","volume":"82","author":"Trautner BW","year":"2025","unstructured":"Trautner BW, Cort\u00e9s-Penfield NW, Gupta K, et al. Clinical practice guideline by Infectious Diseases Society of America (IDSA): 2025 guideline on management and treatment of complicated urinary tract infections: selection of antibiotic therapy for complicated UTI. Clin Infect Dis. 2025;82(Supplement_3):i36\u2013i67.","journal-title":"Clin Infect Dis"},{"key":"e_1_3_5_37_1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201908-1581ST"},{"key":"e_1_3_5_38_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2017.77.6211"},{"key":"e_1_3_5_39_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciu296"},{"key":"e_1_3_5_40_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciu444"},{"key":"e_1_3_5_41_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cis966"},{"key":"e_1_3_5_42_1","unstructured":"Canadian Urological Association. Canadian undergraduate urology curriculum (Can UUC): urinary tract infections. 2026 May 29. Available from: https:\/\/www.cua.org\/sites\/default\/files\/CanUUC\/CanUUC-UTI-2019.pdf"},{"key":"e_1_3_5_43_1","unstructured":"European Association of Urology. EAU guidelines on urological infections. 2026 May 29. Available from: https:\/\/uroweb.org\/guidelines\/urological-infections\/chapter\/the-guideline"},{"key":"e_1_3_5_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jiac.2017.02.002"},{"key":"e_1_3_5_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0924-8579(98)00107-1"},{"issue":"2","key":"e_1_3_5_46_1","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0924-8579(98)00107-1","article-title":"Formula to help select rational antimicrobial therapy (FRAT): its application to community and hospital acquired urinary tract infections","volume":"12","author":"Blondeau JM","year":"1999","unstructured":"Blondeau JM, Tillotson GS. Formula to help select rational antimicrobial therapy (FRAT): its application to community and hospital acquired urinary tract infections. Int J Antimicrob Agents. 1999;12(2):145\u2013150.","journal-title":"Int J Antimicrob Agents"},{"key":"e_1_3_5_47_1","doi-asserted-by":"publisher","DOI":"10.1211\/PJ.2024.1.329050"},{"issue":"49","key":"e_1_3_5_48_1","doi-asserted-by":"crossref","first-page":"e2411919121","DOI":"10.1073\/pnas.2411919121","article-title":"Global trends in antibiotic consumption during 2016\u20132023 and future projections through 2030","volume":"121","author":"Klein EY","year":"2024","unstructured":"Klein EY, Impalli I, Poleon S, et al. Global trends in antibiotic consumption during 2016\u20132023 and future projections through 2030. Proc Natl Acad Sci USA. 2024;121(49):e2411919121.","journal-title":"Proc Natl Acad Sci USA"},{"key":"e_1_3_5_49_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1439-0450.2004.00788.x"},{"key":"e_1_3_5_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vetmic.2020.108637"},{"key":"e_1_3_5_51_1","doi-asserted-by":"publisher","DOI":"10.3390\/biom16070984"},{"key":"e_1_3_5_52_1","doi-asserted-by":"publisher","DOI":"10.3122\/jabfm.2008.01.070071"}],"container-title":["Expert Review of Anti-infective Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14787210.2026.2740110","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/full-xml\/10.1080\/14787210.2026.2740110","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14787210.2026.2740110","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T13:46:20Z","timestamp":1790689580000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14787210.2026.2740110"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,29]]},"references-count":50,"alternative-id":["10.1080\/14787210.2026.2740110"],"URL":"https:\/\/doi.org\/10.1080\/14787210.2026.2740110","relation":{},"ISSN":["1478-7210","1744-8336"],"issn-type":[{"value":"1478-7210","type":"print"},{"value":"1744-8336","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,29]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierz20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierz20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2026-06-08","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-09-23","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-09-29","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}